Open-access database of literature derived drug-related Torsade de Pointes cases
Abstract Since an introduction of an ICH guidance in 2005, no new drugs were withdrawn from the market because of the causation of Torsade de Pointes (TdP). However, the risk of TdP is still a concern for marketed drugs. TdP is a type of polymorphic ventricular tachycardia which may lead to sudden c...
Saved in:
Main Authors: | Krumpholz Laura (Author), Wiśniowska Barbara (Author), Polak Sebastian (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction to: Open-access database of literature derived drug-related Torsade de Pointes cases
by: Laura Krumpholz, et al.
Published: (2022) -
Torsades de Pointes
by: Richard J Chen, MD, et al.
Published: (2018) -
Refractory Torsades de Pointes Due to Dofetilide Overdose
by: James Crosby DO, et al.
Published: (2021) -
A Case of Ciprofloxacin-Induced QT Prolongation and Torsade de Pointes
by: Hedieh Keshavarz-Bahaghighat, et al.
Published: (2017) -
Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023)